The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development

Human Vaccines

Volumn 6, Issue 1, 2010, Pages

  Hviid, Lars ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Antibodies; Immunity; Malaria; PfEMP1; Vaccines; Variant surface antigens

Indexed keywords

ERYTHROCYTE MEMBRANE PROTEIN 1; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG; VARIANT SURFACE ANTIGEN; ERYTHROCYTE MEMBRANE PROTEIN 1, PLASMODIUM FALCIPARUM; MEMBRANE ANTIGEN; PROTOZOAL PROTEIN; VAR2CSA PROTEIN, PLASMODIUM FALCIPARUM;

ANTIGENIC VARIATION; DISEASE SEVERITY; HUMAN; INNATE IMMUNITY; MALARIA FALCIPARUM; MATERNAL MORBIDITY; MATERNAL MORTALITY; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLASMODIUM FALCIPARUM; PREGNANCY; REVIEW; VACCINE PRODUCTION; FEMALE; IMMUNOLOGY; PREGNANCY COMPLICATION;

ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; FEMALE; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROTOZOAN PROTEINS;

EID: 85046915383     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.1.9602     Document Type: Review

References (88)

1. Owusu-Agyei S, Koram KA, Baird JK, Utz GC, Binka FN, Nkrumah FK, et al. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 2001; 65:197-203.
2. Hviid L. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop 2005; 95:270-5.
3. Hviid L. The immuno-epidemiology of pregnancyassociated malaria: a variant surface antigen-specific perspective. Parasite Immunol 2004; 26:477-86.
4. Hviid L, Staalsoe T. Malaria immunity in infants: a special case of a general phenomenon? Trends Parasitol 2004; 20:66-72.
5. Trager W, Rudzinska MA, Bradbury PC. The fine structure of Plasmodium falciparum and its host erythrocytes in natural malarial infections in man. Bull World Health Organ 1966; 35:883-5.
6. Miller LH. The ultrastructure of red cells infected by Plasmodium falciparum in man. Trans R Soc Trop Med Hyg 1972; 66:459-62.
7. Luse SA, Miller LH. Plasmodium falciparum malaria. Ultrastructure of parasitized erythrocytes in cardiac vessels. Am J Trop Med Hyg 1971; 20:655-60.
8. Hommel M, David PH, Oligino LD. Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen. J Exp Med 1983; 157:1137-48.
9. Staalsoe T, Hamad AA, Hviid L, Elhassan IM, Arnot DE, Theander TG. In vivo switching between variant surface antigens in human Plasmodium falciparum infection. J Infect Dis 2002; 186:719-22.
10. MacPherson GG, Warrell MJ, White NJ, Looaresuwan S, Warrell DA. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 1985; 119:385-401.
11. Corbett CE, Duarte MI, Lancellotti CL, Silva MA, Andrade Junior HF. Cytoadherence in human falciparum malaria as a cause of respiratory distress. J Trop Med Hyg 1989; 92:112-20.
12. McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 1984; 33:517-25.
13. Kilejian A, Abati A, Trager W. Plasmodium falciparum and Plasmodium coatneyi: immunogenicity of "knob-like protrusions" on infected erythrocyte membranes. Exp Parasitol 1977; 42:157-64.
14. Langreth SG, Reese RT. Antigenicity of the infectederythrocyte and merozoite surfaces in falciparum malaria. J Exp Med 1979; 150:1241-54.
15. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci USA 1983; 80:5075-9.
16. Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991; 164:163-9.
17. Turner GDH, Morrison H, Jones M, Davis TME, Looareesuwan S, Buley ID, et al. An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994; 145:1057-69.
18. Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 1997; 57:389-98.
19. Rogerson SJ, Tembenu R, Dobaño C, Plitt S, Taylor TE, Molyneux ME. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg 1999; 61:467-72.
20. Smith JD, Craig AG, Kriek N, Hudson-Taylor D, Kyes S, Fagen T, et al. Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proc Natl Acad Sci USA 2000; 97:1766-71.
21. Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990; 336:1457-60.
22. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995; 63:2323-6.
23. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complementreceptor 1. Nature 1997; 388:292-5.
24. Chen Q, Barragan A, Fernandez V, Sundstrom A, Schlichtherle M, Sahlen A, et al. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med 1998; 187:15-23.
25. Vigan-Womas I, Guillotte M, Le Scanf C, Igonet S, Petres S, Juillerat A, et al. An in vivo/in vitro model of rosetting and autoagglutination mediated by Plasmodium falciparum VarO, a group A var gene encoding a frequent serotype. Infect Immun 2007; 76:5565-80.
26. Mercereau-Puijalon O, Guillotte M, Vigan-Womas I. Rosetting in Plasmodium falciparum: A cytoadherence phenotype with multiple actors. Transfus Clin Biol 2008; 15:62-71.
27. Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A, Twumasi P, et al. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 1992; 46:503-10.
28. Heddini A, Pettersson F, Kai O, Shafi J, Obiero J, Chen Q, et al. Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 2001; 69:5849-56.
29. Rowe JA, Obiero J, Marsh K, Raza A. Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. Am J Trop Med Hyg 2002; 66:458-60.
30. Udomsangpetch R, Reinhardt PH, Schollaardt T, Elliott JF, Kubes P, Ho M. Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol 1997; 158:4358-64.
31. Chen QJ, Heddini A, Barragan A, Fernandez V, Pearce SFA, Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 2000; 192:1-9.
32. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 1996; 272:1502-4.
33. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis 1999; 180:464-72.
34. Salanti A, Staalsoe T, Lavstsen T, Jensen ATR, Sowa MPK, Arnot DE, et al. Selective upregulation of a single distinctly structured var gene in CSA-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003; 49:179-91.
35. Salanti A, Dahlbäck M, Turner L, Nielsen MA, Barfod L, Magistrado P, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004; 200:1197-203.
36. Viebig NK, Gamain B, Scheidig C, Lepolard C, Przyborski J, Lanzer M, et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Reports 2005; 6:775-81.
37. Duffy MF, Maier AG, Byrne TJ, Marty AJ, Elliott SR, O'Neill MT, et al. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol 2006; 148:117-24.
38. Gamain B, Trimnell AR, Scheidig C, Scherf A, Miller LH, Smith JD. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005; 191:1010-3.
39. Resende M, Nielsen MA, Dahlback M, Ditlev SB, Andersen P, Sander AF, et al. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA. Malar J 2008; 7:104.
40. Buffet PA, Gamain B, Scheidig C, Baruch D, Smith JD, Hernandez-Rivas R, et al. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA 1999; 96:12743-8.
41. Degen R, Weiss N, Beck HP. Plasmodium falciparum: cloned and expressed CIDR domains of PfEMP1 bind to chondroitin sulfate A. Exp Parasitol 2000; 95:113-21.
42. Resende M, Ditlev SB, Nielsen MA, Bodevin S, Bruun S, Pinto VV, et al. Chondroitin sulphate A (CSA)-binding of single recombinant Duffybinding-like domains is not restricted to Plasmodium falciparum erythrocyte membrane protein 1 expressed by CSA-binding parasites. Int J Parasitol (in press).
43. Marsh K, Howard RJ. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 1986; 231:150-3.
44. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell are targets for naturally acquired immunity to malaria. Nat Med 1998; 4:358-60.
45. Giha HA, Staalsoe T, Dodoo D, Elhassan IM, Roper C, Satti GM, et al. Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect Immun 1999; 67:4092-8.
46. Ofori MF, Dodoo D, Staalsoe T, Kurtzhals JAL, Koram K, Theander TG, et al. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immun 2002; 70:2982-8.
47. Duffy PE, Desowitz RS. Pregnancy malaria throughout history: dangerous labors. Duffy PE, Fried M. Malaria in pregnancy. Deadly parasite, susceptible host. London, Taylor & Francis. Ref Type: Book Chapter 2001; 1:1-25.
48. Nguyen-Dinh P, Steketee RW, Greenberg AE, Wirima JJ, Mulenda O, Williams SB. Rapid spontaneous postpartum clearance of Plasmodium falciparum parasitaemia in African women. Lancet 1988; 2:751-2.
49. Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulphate A. J Immunol 2000; 165:3309-16.
50. Tuikue Ndam NG, Salanti A, Le-Hesran J-Y, Cottrell G, Fievet N, Turner L, et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of Senegalese pregnant women. J Infect Dis 2006; 193:713-20.
51. Ofori MF, Staalsoe T, Bam V, Lundquist M, David KP, Browne ENL, et al. Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection. Infect Immun 2003; 71:1584-6.
52. Fried M, Nosten F, Brockman A, Brabin BT, Duffy PE. Maternal antibodies block malaria. Nature 1998; 395:851-2.
53. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003; 71:6620-3.
54. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against the clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363:283-9.
55. Bull PC, Lowe BS, Kortok M, Marsh K. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun 1999; 67:733-9.
56. Bull PC, Kortok M, Kai O, Ndungu F, Ross A, Lowe BS, et al. Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. J Infect Dis 2000; 182:252-9.
57. Nielsen MA, Staalsoe T, Kurtzhals JAL, Goka BQ, Dodoo D, Alifrangis M, et al. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and non-severe malaria and is modified by acquired immunity. J Immunol 2002; 168:3444-50.
58. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987; 81:478-86.
59. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 1999; 5:340-3.
60. Jensen ATR, Magistrado PA, Sharp S, Joergensen L, Lavstsen T, Chiucchiuini A, et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by Group A var genes. J Exp Med 2004; 199:1179-90.
61. Kraemer SM, Smith JD. Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family. Mol Microbiol 2003; 50:1527-38.
62. Lavstsen T, Salanti A, Jensen ATR, Arnot DE, Theander TG. Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar J 2003; 2:27.
63. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, Marsh K, et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992; 357:689-92.
64. Lavstsen T, Magistrado P, Hermsen CC, Salanti A, Jensen ATR, Sauerwein R, et al. Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans. Malar J 2005; 4:21.
65. Collins WE, Jeffery GM. A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am J Trop Med Hyg 1999; 61:44-8.
66. Rottmann M, Lavstsen T, Mugasa JP, Kaestli M, Jensen ATR, Müller D, et al. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect Immun 2006; 74:3904-11.
67. Joergensen L, Turner L, Magistrado P, Dahlbäck M, Vestergaard L, Lusingu JP, et al. Limited crossreactivity among domains of the 3D7 Plasmodium falciparum erythrocyte membrane protein 1 family. Infect Immun 2006; 74:6778-84.
68. Joergensen L, Vestergaard LS, Turner L, Magistrado P, Lusingu JP, Lemnge M, et al. 3D7-derived Plasmodium falciparum erythrocyte membrane protein 1 is a frequent target of naturally acquired antibodies recognizing protein domains in a particular pattern independent of malaria transmission intensity. J Immunol 2007; 178:428-35.
69. Staalsoe T, Megnekou R, Fievet N, Ricke CH, Zornig HD, Leke R, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that are associated with protection against placental parasitemia. J Infect Dis 2001; 184:618-26.
70. O'Neill-Dunne I, Achur RN, Agbor-Enoh ST, Valiyaveettil M, Naik RS, Ockenhouse CF, et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 2001; 69:7487-92.
71. Greenwood BM, Marsh K, Snow R. Why do some children develop severe malaria? Parasitol Today 1991; 7:277-81.
72. Fernandez V, Hommel M, Chen QJ, Hagblom P, Wahlgren M. Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med 1999; 190:1393-403.
73. Kyes SA, Rowe JA, Kriek N, Newbold CI. Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci USA 1999; 96:9333-8.
74. Sam-Yellowe TY, Florens L, Johnson JR, Wang T, Drazba JA, Le Roch KG, et al. A Plasmodium gene family encoding Maurer's cleft membrane proteins: structural properties and expression profiling. Genome Res 2004; 14:1052-9.
75. Blythe JE, Yam XY, Kuss C, Bozdech Z, Holder AA, Marsh K, et al. Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infect Immun 2008; 76:3329-36.
76. Niang M, Yan YX, Preiser PR. The Plasmodium falciparum STEVOR multigene family mediates antigenic variation of the infected erythrocyte. PLoS Pathog 2009; 5:1000307.
77. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995; 82:77-87.
78. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995; 82:101-10.
79. Su X, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995; 82:89-100.
80. Dahlbäck M, Rask TS, Andersen PH, Nielsen MA, Tuikue-Ndam NG, Resende M, et al. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in Plasmodium falciparum placental sequestration. PLoS Pathog 2006; 2:124.
81. Avril M, Kulasekara BR, Gose SO, Rowe C, Dahlbäck M, Duffy PE, et al. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy malaria vaccine candidate VAR2CSA. Infect Immun 2007; 76:1791-800.
82. Barfod L, Bernasconi N, Dahlbäck M, Jarrosay D, Andersen PH, Salanti A, et al. Human pregnancyassociated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Mol Microbiol 2007; 63:335-47.
83. Andersen P, Nielsen MA, Resende M, Rask TS, Dahlbäck M, Theander T, et al. Structural insights into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog 2008; 4:42.
84. Avril M, Gamain B, Lepolard C, Viaud N, Scherf A, Gysin J. Characterisation of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. Microbes Infect 2006; 8:2863-71.
85. Nielsen MA, Pinto VV, Resende M, Dahlbäck M, Andersen P, Ditlev SB, et al. Induction of adhesioninhibitory antibodies against placental Plasmodium falciparum parasites using single domains of VAR2CSA. Infect Immun 2009; 77:2482-7.
86. Makobongo MO, Keegan B, Long CA, Miller LH. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1α protects against severe disease during Plasmodium falciparum reinfection. J Infect Dis 2006; 193:731-40.
87. Moll K, Pettersson F, Vogt AM, Jonsson C, Rasti N, Ahuja S, et al. Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-Duffy binding-like 1α domain. Infect Immun 2006; 75:211-9.
88. Klein MM, Gittis AG, Su H-P, Makobongo MO, Moore JM, Singh S, et al. The cysteine-rich interdomain region from the highly variable Plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathog 2008; 4:1000147.